INSM1 expression is frequent in primary central nervous system neoplasms but not in the adult brain parenchyma

Research output: Contribution to journalArticle

Abstract

Tumors with a neuronal component comprise a small percentage of central nervous system (CNS) neoplasms overall, but the presence of neuronal differentiation has important diagnostic, prognostic, and therapeutic implications. Insulinoma-associated protein 1 (INSM1) is a transcription factor with strong nuclear immunostaining in neuroendocrine cells and neoplasms of neuroendocrine origin; however, its expression in the CNS in normal brain and in neoplastic cells has not been fully explored. Here, we present immunostaining results from a large number of archival CNS tissue specimens, including 416 tumors. Nuclear immunostaining for INSM1 was frequently seen in medulloblastomas (87%, n=94). Diffuse nuclear INSM1 immunostaining was detected in all central neurocytomas and pituitary adenomas. Patchy to rare staining with INSM1 was also seen in other high-grade embryonal tumors and high-grade gliomas. In normal brain tissue, specific nuclear INSM1 immunohistochemical staining was only seen in early neuronal development. Notably, nuclear INSM1 staining was not seen in adult normal brain, including areas of gliosis. These findings indicate that nuclear INSM1 immunostaining may serve as a strong nuclear marker in the brain for neoplasms of neuroendocrine or immature neuronal differentiation, when used in concert with other immunostains.

Original languageEnglish (US)
Pages (from-to)374-382
Number of pages9
JournalJournal of Neuropathology and Experimental Neurology
Volume77
Issue number5
DOIs
StatePublished - May 1 2018

Fingerprint

Central Nervous System Neoplasms
Insulinoma
Brain
Proteins
Staining and Labeling
Neoplasms
Central Nervous System
Neurocytoma
Nerve Tissue
Neuroendocrine Cells
Medulloblastoma
Gliosis
Pituitary Neoplasms
Brain Neoplasms
Glioma
Transcription Factors

Keywords

  • Biomarker
  • Immunohistochemistry
  • INSM1
  • Medulloblastoma
  • Neurodevelopment
  • Neuroendocrine

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

@article{c66d730e562f491aad71f204f7ce829d,
title = "INSM1 expression is frequent in primary central nervous system neoplasms but not in the adult brain parenchyma",
abstract = "Tumors with a neuronal component comprise a small percentage of central nervous system (CNS) neoplasms overall, but the presence of neuronal differentiation has important diagnostic, prognostic, and therapeutic implications. Insulinoma-associated protein 1 (INSM1) is a transcription factor with strong nuclear immunostaining in neuroendocrine cells and neoplasms of neuroendocrine origin; however, its expression in the CNS in normal brain and in neoplastic cells has not been fully explored. Here, we present immunostaining results from a large number of archival CNS tissue specimens, including 416 tumors. Nuclear immunostaining for INSM1 was frequently seen in medulloblastomas (87{\%}, n=94). Diffuse nuclear INSM1 immunostaining was detected in all central neurocytomas and pituitary adenomas. Patchy to rare staining with INSM1 was also seen in other high-grade embryonal tumors and high-grade gliomas. In normal brain tissue, specific nuclear INSM1 immunohistochemical staining was only seen in early neuronal development. Notably, nuclear INSM1 staining was not seen in adult normal brain, including areas of gliosis. These findings indicate that nuclear INSM1 immunostaining may serve as a strong nuclear marker in the brain for neoplasms of neuroendocrine or immature neuronal differentiation, when used in concert with other immunostains.",
keywords = "Biomarker, Immunohistochemistry, INSM1, Medulloblastoma, Neurodevelopment, Neuroendocrine",
author = "Ames, {Heather M.} and Lisa Rooper and Laterra, {John J} and Eberhart, {Charles G} and Rodriguez, {Fausto J}",
year = "2018",
month = "5",
day = "1",
doi = "10.1093/jnen/nly014",
language = "English (US)",
volume = "77",
pages = "374--382",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - INSM1 expression is frequent in primary central nervous system neoplasms but not in the adult brain parenchyma

AU - Ames, Heather M.

AU - Rooper, Lisa

AU - Laterra, John J

AU - Eberhart, Charles G

AU - Rodriguez, Fausto J

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Tumors with a neuronal component comprise a small percentage of central nervous system (CNS) neoplasms overall, but the presence of neuronal differentiation has important diagnostic, prognostic, and therapeutic implications. Insulinoma-associated protein 1 (INSM1) is a transcription factor with strong nuclear immunostaining in neuroendocrine cells and neoplasms of neuroendocrine origin; however, its expression in the CNS in normal brain and in neoplastic cells has not been fully explored. Here, we present immunostaining results from a large number of archival CNS tissue specimens, including 416 tumors. Nuclear immunostaining for INSM1 was frequently seen in medulloblastomas (87%, n=94). Diffuse nuclear INSM1 immunostaining was detected in all central neurocytomas and pituitary adenomas. Patchy to rare staining with INSM1 was also seen in other high-grade embryonal tumors and high-grade gliomas. In normal brain tissue, specific nuclear INSM1 immunohistochemical staining was only seen in early neuronal development. Notably, nuclear INSM1 staining was not seen in adult normal brain, including areas of gliosis. These findings indicate that nuclear INSM1 immunostaining may serve as a strong nuclear marker in the brain for neoplasms of neuroendocrine or immature neuronal differentiation, when used in concert with other immunostains.

AB - Tumors with a neuronal component comprise a small percentage of central nervous system (CNS) neoplasms overall, but the presence of neuronal differentiation has important diagnostic, prognostic, and therapeutic implications. Insulinoma-associated protein 1 (INSM1) is a transcription factor with strong nuclear immunostaining in neuroendocrine cells and neoplasms of neuroendocrine origin; however, its expression in the CNS in normal brain and in neoplastic cells has not been fully explored. Here, we present immunostaining results from a large number of archival CNS tissue specimens, including 416 tumors. Nuclear immunostaining for INSM1 was frequently seen in medulloblastomas (87%, n=94). Diffuse nuclear INSM1 immunostaining was detected in all central neurocytomas and pituitary adenomas. Patchy to rare staining with INSM1 was also seen in other high-grade embryonal tumors and high-grade gliomas. In normal brain tissue, specific nuclear INSM1 immunohistochemical staining was only seen in early neuronal development. Notably, nuclear INSM1 staining was not seen in adult normal brain, including areas of gliosis. These findings indicate that nuclear INSM1 immunostaining may serve as a strong nuclear marker in the brain for neoplasms of neuroendocrine or immature neuronal differentiation, when used in concert with other immunostains.

KW - Biomarker

KW - Immunohistochemistry

KW - INSM1

KW - Medulloblastoma

KW - Neurodevelopment

KW - Neuroendocrine

UR - http://www.scopus.com/inward/record.url?scp=85047135072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047135072&partnerID=8YFLogxK

U2 - 10.1093/jnen/nly014

DO - 10.1093/jnen/nly014

M3 - Article

C2 - 29490065

AN - SCOPUS:85047135072

VL - 77

SP - 374

EP - 382

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 5

ER -